NCT04929028 2026-03-18
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
15 trialsNCT04166318 2026-03-02
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT05838391 2026-02-03
Adaptive Radiation in Anal Cancer
Columbia University
Phase NA Recruiting
NCT05902533 2025-12-18
REDEL
University of Cincinnati
Phase 2/3 Active not recruiting
NCT06207981 2025-09-02
KANALRAD
Federation Francophone de Cancerologie Digestive
Phase 3 Recruiting
NCT04046133 2025-08-05
CORINTH
Cardiff University
Phase 1 Active not recruiting
NCT03018418 2024-09-19
Proton Therapy in Reducing Toxicity in Anal Cancer
University of Cincinnati
Phase 2 Active not recruiting
NCT01324141 2021-11-23
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT02526953 2021-02-09
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
Blokhin's Russian Cancer Research Center
Phase 3 Unknown
NCT01621217 2020-02-28
NOAC8
Lund University Hospital
Phase 1 Completed
NCT03381352 2018-01-30
Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer
ChineseAMS
Phase 2 Unknown
NCT02369939 2017-08-11
HYCAN
University of Erlangen-Nürnberg Medical School
Phase 3 Unknown
NCT00003596 2017-01-04
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00025090 2013-08-26
Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00068744 2012-09-24
Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Terminated